Revolution Medicines, Inc 10-Q for FY2025 Q3
Revolution Medicines, Inc. (RVMD)
10-Q
2025-11-05
For: 2025-09-30
View Original
Added on
April 10, 2026
About this 10-Q
Revolution Medicines, Inc filed this 10-Q on November 5, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).
Headline figures
Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $305.21M
- compared with a net loss of $156.29M a year earlier
- Diluted EPS
- -$1.61
- compared with -$0.94 a year earlier